Dawson James Reiterates Dyadic International (DYAI) at Buy, $6 PT, Sees 20% Probability of Success of C1 Platform

Dawson James analyst Jason Kolbert reiterated a Buy rating and $6.00 price target on Dyadic International (NASDAQ: DYAI).

The analyst quotes: "If we flip a coin four times, the reality is we have no idea how many times it will be heads vs. tails. The same thing is true regarding our ability to predict the next partnership or license deal. If we flip a coin a hundred times, we can expect about half of the tosses to be heads (or tails). For Dyadic, we broadly evaluate the utility of the C1 platform across several market segments such as the Pharma and Biotechnology areas, Biosimilars, Vaccines, and Industrial markets. For this modeling exercise, we apply a +/- 80% discount (or 20% +/- the probability of success) factor to determine the revenue stream. This discount is in addition to our (r) discount rate that we use in our Free Cash Flow to the Firm (FCFF), discounted EPS (dEPS), and Sum of the Parts (SOP) models. For this rate, we select r = 15%. Our model uses a fully diluted projected out-year (2030) share count. Our three models (FCFF, dEPS, and SOP) are then equal-weighted, averaged, and rounded to the nearest whole number to derive our 12-month price target of $6.00."

For an analyst ratings summary and ratings history on Dyadic International click here. For more ratings news on Dyadic International click here.

Shares of Dyadic International closed at $3.50 yesterday.

By Vlad Schepkov | [email protected]

You May Also Be Interested In

• Dyadic International (DYAI) PT Lowered to $4 at Craig-Hallum
• Cantor Fitzgerald Reiterates Overweight Rating on Applied Materials (AMAT)
• Intuitive Machines Inc. (LUNR) PT Lowered to $32 at Cantor Fitzgerald, Reaffirms Overweight Rating